Skip to main content
UniHealth

Doctor search

Christopher R Kieliszak, DO

Plastic and Reconstructive Surgery · Tampa

NPI 1346508421

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
9

Offices

9 locations · Palm Harbor Dermatology PA · Lakeland Regional Health Systems Inc · Western New York Medical Practice PC · Rochester General Hospital

Looking this up.

Hospitals listed: Rochester General Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kieliszak’s office to ask if they take your plan before you enroll.

State licence records

1 licence

  • Florida OS19621Osteopathic Physician · since 2023 · expires 2028-03-31Matched by name, not licence number; check the name before relying on it.
    ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

4 placements

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Education

  • New York Institute of Technology Main CA · DO2008–2012Medical school

Residency and fellowship

  • Mittelman Plastic Surgery Center, PLASTIC SURGERY WITHIN THE HEAD AND NECKLOS ALTOS, CA · 2018–2019
  • OhioHealth Doctors Hospital, OTOLARYNGOLOGYColumbus, OH · 2014–2018
  • core doctors hospital, OTOLARYNGOLOGYcolumbus, OH · 2014–2018
  • Adena Regional Medical Center, OSTEOPATHIC INTERNSHIP/RESIDENCYChillicothe, OH · 2012–2013

What else the board holds

Hospitals they may admit to

Where the clinician told their state board they may admit and treat patients.

  • Out of State · FL

Also licensed in

States the clinician told their board they are also licensed in. Only the states we check are verified.

California

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Rochester General HospitalRochester, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Rochester Regional Health System, which runs 6 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend it
    Overall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.75 (1.49 to 2.01), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.59 (3.69 to 7.49) · 1,934 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative hemorrhage or hematoma rate: 4.42 (3.1 to 5.73) · 1,826 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.27 (1.72 to 2.82) · 5,687 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.544, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.477, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.522, Oct 2024 – Sep 2025
See every measure and the patient survey for Rochester General Hospital

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 2 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Rochester General Hospital
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.75 (1.49 to 2.01)WorseJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.59 (3.69 to 7.49) · 1,934 casesWorseJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths4.42 (3.1 to 5.73) · 1,826 casesWorseJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths2.27 (1.72 to 2.82) · 5,687 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.544BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.477BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.522BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.54 (0.63 to 2.45) · 1,327 casesNo differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths173.53 (128.98 to 218.07) · 110 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.6 · 70 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.9 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.6 · 142 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.7 · 346 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 240 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.8 · 634 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.8 · 7,150 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.35 (0.15 to 0.55) · 6,752 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.39 (0.19 to 0.58) · 7,066 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.46 (0.03 to 2.88) · 986 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths11.02 (6.1 to 15.95) · 952 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.01 (3.93 to 10.09) · 992 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.82 (0.4 to 3.24) · 419 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.3 · 264 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.674No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections1.728No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.49No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.7 · 678 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.8 · 1,625 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits56.1 · 188 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits44.4 · 417 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits84.2 · 233 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17 · 944 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.1 (2.7 to 6) · 145 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits8.9 (6.5 to 12) · 145 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits7.7 · 261 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.9 · 188 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.4 · 508 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (9.5 to 17) · 396 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.2) · 590 casesNo differentJan 2024 – Dec 2024

What patients said (3,464 patients answered, 23% of those asked)

Patient survey stars by topic at Rochester General Hospital
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness2
Recommend hospital2
Share of patients giving the best answer at Rochester General Hospital
Room was "always" clean58%
Nurses "always" communicated well71%
Doctors "always" communicated well74%
Staff "always" explained53%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect81%
Patients who gave a rating of "9" or "10" (high)59%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand67%
Nurses "always" listened carefully68%
Nurses "always" treated them with courtesy and respect78%
"Always" quiet at night43%
"YES", patients would definitely recommend the hospital60%
Staff "always" explained possible side effects39%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$1,927

Medicare paid this office $1,927 for 24 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Procedures Medicare counted

Procedure volume Medicare published
Melanoma (skin cancer) excision1-10None
Removal of skin lesions1-10None
Skin biopsy1-10None

Who their Medicare patients are

24 Original Medicare patients in 2024. Average age 72 · Also on Medicaid 46% · Health risk score 1.40. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.

Conditions among them: High blood pressure 75%.

The office billed $7,361, Medicare allowed $3,151 and paid $1,927; for 38 services of 13 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242438721.40$7,361$1,927
2023108226690.96$43,229$12,864
2022110335711.07$50,829$18,168
202191287681.48$64,041$25,153
2020114308661.47$48,432$20,457
20192959681.50$10,132$4,642

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Short return visit (20+ min)48$2,711$51
Diagnostic exam of voice box using a flexible endoscope22$1,276$55
New patient visit (30+ min)20$1,273$64
New patient visit (45+ min)12$1,186$99
Removal of impacted ear wax12$409$29

2022: 9 services

Original Medicare services billed in 2022
Short return visit (20+ min)44$2,560$53
Diagnostic exam of voice box using a flexible endoscope28$2,245$70
Return visit (30+ min)24$2,228$83
New patient visit (30+ min)32$1,913$60
New patient visit (45+ min)12$1,147$96
Diagnostic exam of nasal passages using an endoscope11$1,104$92
Professional service for multiple injections of allergen21$696$8
Comprehensive hearing and speech recognition test12$240$20
Test to assess middle ear function12$85$7

2021: 9 services

Original Medicare services billed in 2021
Short return visit (20+ min)43$3,917$68
Diagnostic exam of voice box using a flexible endoscope20$2,408$89
Diagnostic exam of nasal passages using an endoscope17$2,203$130
New patient visit (30+ min)27$2,029$75
New patient visit (45+ min)14$1,744$125
Return visit (30+ min)14$1,662$87
Comprehensive hearing and speech recognition test16$478$28
Removal of impacted ear wax12$418$30
Test for eardrum and muscle function17$296$16

2020: 6 services

Original Medicare services billed in 2020
Short return visit (20+ min)68$4,735$55
Diagnostic exam of nasal passages using an endoscope16$2,705$150
New patient visit (30+ min)32$2,571$80
Diagnostic exam of voice box using a flexible endoscope20$2,046$85
Comprehensive hearing and speech recognition test19$664$30
Test for eardrum and muscle function20$405$17

2019: 2 services

Original Medicare services billed in 2019
Short return visit (20+ min)14$908$57
New patient visit (30+ min)11$907$82

Medicaid work

$273 in 2023

Medicaid paid $273 for 31 billed services this clinician did in 2023, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections31$273
Medicaid work by year
202331113$273
2022111121$987
2020136227$10,288
201920119$1,189
See the largest Medicaid services in earlier years

2022

Largest Medicaid services in 2022
Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections111$987

2020

Largest Medicaid services in 2020
Short return visit (20+ min)90$5,854
New patient visit (30+ min)46$4,434

2019

Largest Medicaid services in 2019
Short return visit (20+ min)20$1,189

Drugs they prescribed that Part D paid

$1,489

Pharmacies billed $1,489 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 12% of their Part D prescriptions (12 of 100) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.

96 generic and fewer than 11 brand-name prescriptions · $1,489 in drug cost · 25 antibiotic prescriptions to 20 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Cephalexin11$45$3

Year by year

Part D prescribing by year
20241003812% (12)None$1,489
202316391None13%$41,063
20222561256% (16)7%$8,297
20212871186% (16)6%$10,190
20203281205% (15)7%$9,853
20191096412% (13)18%$4,576
20185426NoneNone$1,230
2017623418% (11)0%$1,084
2016774023% (18)None$898
20153116NoneNone$642
20142212NoneNone$580
201310016NoneNone$3,344

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Mometasone Furoate11$764$69
Azelastine11$272$25
Fluticasone Propionate13$213$16
Amoxicillin12$36$3

2022: 7 drugs

Part D drugs prescribed in 2022
Ipratropium21$1,224$58
Fluticasone Propionate43$750$17
Azelastine17$645$38
Levothyroxine14$253$18
Hydrocodone-Acetaminophen16$179$11
Famotidine12$101$8
Mupirocin14$97$7

2021: 9 drugs

Part D drugs prescribed in 2021
Ciprofloxacin-Dexamethasone12$2,196$183
Ipratropium31$1,711$55
Fluticasone Propionate48$1,349$28
Azelastine36$1,259$35
Famotidine18$288$16
Hydrocodone-Acetaminophen15$87$6
Mupirocin11$76$7
Montelukast15$64$4
Clindamycin11$41$4

2020: 11 drugs

Part D drugs prescribed in 2020
Fluticasone Propionate64$1,059$17
Ipratropium22$939$43
Famotidine25$470$19
Azelastine14$409$29
Montelukast33$283$9
Amoxicillin-Clavulanate Potass13$184$14
Mupirocin12$77$6
Hydrocodone-Acetaminophen15$63$4
Clindamycin11$42$4
Cephalexin13$36$3
Prednisone11$30$3

2019: 3 drugs

Part D drugs prescribed in 2019
Ciprodex11$2,727$248
Hydrocodone-Acetaminophen13$82$6
Cephalexin13$69$5

2017: 1 drug

Part D drugs prescribed in 2017
Fluticasone Propionate12$147$12

2016: 2 drugs

Part D drugs prescribed in 2016
Ranitidine21$179$9
Fluticasone Propionate13$150$12

2013: 3 drugs

Part D drugs prescribed in 2013
Risperidone18$164$9
Propylthiouracil17$124$7
Phenytoin Sodium Extended15$94$6

Money from drug and device companies

$59 in 2025

Industry payments by year
202523None$59
202333None$185
2022510None$334
202144None$434
202057None$490
201944None$195

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GlaxoSmithKlineNucala$40
2 payments
  • Meals for Nucala · 2025-03-13 · $22
  • Meals for Nucala · 2025-01-30 · $18
StrykerScopis Ent$20
1 payment
  • Meals for Scopis Ent · 2025-04-10 · $20
See all 3 published payments
Every published payment
StrykerMeals · 2025-04-10Scopis Ent$20
GlaxoSmithKlineMeals · 2025-03-13Nucala$22
GlaxoSmithKlineMeals · 2025-01-30Nucala$18
See earlier years (2023, 2022, 2021, 2020, 2019)

2023: $185

Payments by company in 2023
GlaxoSmithKlineNucala$112
1 payment
  • Meals for Nucala · 2023-06-13 · $112
StrykerScopis Ent$47
1 payment
  • Meals for Scopis Ent · 2023-02-06 · $47
Smith+NephewTula$27
1 payment
  • Meals for Tula · 2023-04-05 · $27

2022: $334

Payments by company in 2022
GlaxoSmithKlineNucala$155
6 payments
  • Meals for Nucala · 2022-10-26 · $23
  • Meals for Nucala · 2022-09-07 · $19
  • Meals for Nucala · 2022-09-07 · $2
  • Meals for Nucala · 2022-05-04 · $18
  • Meals for Nucala · 2022-05-04 · $1
  • Meals for Nucala · 2022-04-26 · $92
GenzymeDupixent$96
1 payment
  • Meals for Dupixent · 2022-09-29 · $96
StrykerScopis Ent$38
1 payment
  • Meals for Scopis Ent · 2022-04-05 · $38
Regeneron Healthcare SolutionsDupixent$24
1 payment
  • Meals for Dupixent · 2022-07-27 · $24
ALK-AbelloOdactra$21
1 payment
  • Meals for Odactra · 2022-10-05 · $21

2021: $434

Payments by company in 2021
Aerin MedicalVivaer Stylus$223
1 payment
  • Meals for Vivaer Stylus · 2021-10-02 · $223
StrykerXpress Ent Dilation System$169
1 payment
  • Meals for Xpress Ent Dilation System · 2021-10-04 · $169
AmbuNone$24
1 payment
  • Meals · 2021-12-01 · $24
Optinose USXhance$18
1 payment
  • Meals for Xhance · 2021-11-03 · $18

2020: $490

Payments by company in 2020
Smith+NephewProcise Max$275
3 payments
  • Education for Procise Max · 2020-09-09 · $145
  • Education for Procise Tonsil · 2020-03-03 · $113
  • Meals for Procise Tonsil · 2020-02-10 · $17
StrykerEntellus - Xpress Ent Dilation System$160
1 payment
  • Meals for Entellus - Xpress Ent Dilation System · 2020-02-19 · $160
Regeneron Healthcare SolutionsDupixent$25
1 payment
  • Meals for Dupixent · 2020-01-21 · $25
ALK-AbelloOdactra$20
1 payment
  • Meals for Odactra · 2020-02-13 · $20
Aerin MedicalVivaer$10
1 payment
  • Meals for Vivaer · 2020-02-25 · $10

2019: $195

Payments by company in 2019
VioptixT. Ox Tissue Oximeter$152
1 payment
  • Meals for T. Ox Tissue Oximeter · 2019-04-29 · $152
StrykerEntellus - Xpress Ent Dilation System$16
1 payment
  • Meals for Entellus - Xpress Ent Dilation System · 2019-12-04 · $16
Merz North AmericaXeomin$15
1 payment
  • Meals for Xeomin · 2019-02-06 · $15
OptiNose USXhance$12
1 payment
  • Meals for Xhance · 2019-10-24 · $12

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
95.2 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1346508421
Licence
NY 300797Florida OS19621: Active
Group
Palm Harbor Dermatology PA · Lakeland Regional Health Systems Inc · Western New York Medical Practice PC · Rochester General Hospital
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207YS0123X (207YS0123X)
Mailing address
700 S Harbour Island Blvd Unit 137, Tampa, FL, 33602
NPI first listed
2012-04-26
NPI last updated
2025-08-06
NPI record certified
2025-08-06

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 395 West Ave Ste 301, Canandaigua, NY, 14424 · 4638 Genesee St, Geneseo, NY, 14454 · 810 Altos Oaks Dr, Los Altos, CA, 94024 · 1206 Driving Park Ave, Newark, NY, 14513 · 1425 S Howard Ave, Tampa, FL, 33606